share_log

Chardan Capital Maintains Buy on Cargo Therapeutics, Maintains $28 Price Target

Chardan Capital Maintains Buy on Cargo Therapeutics, Maintains $28 Price Target

Chardan Capital将Cargo Therapeutics的买入评级维持在$28的目标价位
Benzinga ·  11/14 06:11  · 评级/大行评级

Chardan Capital analyst Geulah Livshits maintains Cargo Therapeutics (NASDAQ:CRGX) with a Buy and maintains $28 price target.

Chardan Capital分析师Geulah Livshits维持Cargo Therapeutics(纳斯达克股票代码:CRGX)的买入并维持28美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发